These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 1723446

  • 1. Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass.
    López NC, Corral JL, Rincón LA, Arreaza MR, Giralt J, Galué GA, Barrios YE, Arocha I.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S101-5. PubMed ID: 1723446
    [Abstract] [Full Text] [Related]

  • 2. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ, Jaguste V, Nanivadekar AS.
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Lijnen P, Fagard R, Staessen J, Amery A.
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the effects of nitrendipine and enalapril in essential hypertension.
    Verkaaik R, Hogewind BL, Woittiez AJ.
    J Cardiovasc Pharmacol; 1991 Oct; 18 Suppl 1():S63-6. PubMed ID: 1723460
    [Abstract] [Full Text] [Related]

  • 5. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B, Guy S, Humphreys JE.
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 8. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H, Schmidt J, Derendorf H.
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [Abstract] [Full Text] [Related]

  • 9. Comparison of diltiazem, nitrendipine, and their combination for systemic hypertension and stable angina pectoris.
    Andreyev N, Bichkov I, Skutelis A, Andreyeva T.
    J Cardiovasc Pharmacol; 1991 Jan; 18 Suppl 9():S73-6. PubMed ID: 1725550
    [Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991 Jan; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [Abstract] [Full Text] [Related]

  • 11. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.
    Dahlöf B.
    Blood Press Suppl; 1992 Jan; 6():1-75. PubMed ID: 1345261
    [Abstract] [Full Text] [Related]

  • 12. Long-term hypotensive treatment with nitrendipine in mild to moderate essential hypertension: preliminary results of a placebo-controlled study versus atenolol.
    Palombo C, Marabotti C, Genovesi-Ebert A, Giuliano G, Giaconi S, Fommei E, Mezzasalma L, Ghione S.
    J Cardiovasc Pharmacol; 1987 Jan; 10 Suppl 10():S90-5. PubMed ID: 2455153
    [Abstract] [Full Text] [Related]

  • 13. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R, Meregalli M, Turri D, Nazzari M, Fiorella G, Guffanti EE, Mazzola C.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [Abstract] [Full Text] [Related]

  • 14. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Jun; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 15. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F, Vaur L, Dutrey-Dupagne C, Genes N, Clerson P.
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [Abstract] [Full Text] [Related]

  • 17. [Reduction of the left ventricular mass in essential hypertension patients chronically treated with monotherapy].
    Baglivo HP, Fabregues G, Burrieza HO, Marín M, Esper RJ.
    Medicina (B Aires); 1990 Jan; 50(3):217-24. PubMed ID: 2151823
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 19. Nitrendipine once or twice daily in hypertensive non-insulin-dependent diabetes mellitus.
    Dolben J, Vora J, Smith H, Luzio S, Griffiths D, Vølund A, Owens DR.
    J Cardiovasc Pharmacol; 1991 Jan; 18 Suppl 1():S94-7. PubMed ID: 1723468
    [Abstract] [Full Text] [Related]

  • 20. [Monotherapy with the ACE-inhibitor ramipril or the calcium antagonist nitrendipine in essential hypertension].
    Weidmann P, Frank J, Graf W, Hausammann R, Heuberger T, Kerkhoven P, Probst G, Schudel P, Steinbach C, Müller A.
    Schweiz Med Wochenschr; 1992 Oct 03; 122(40):1497-503. PubMed ID: 1411408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.